Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

AMIX

Autonomix Medical Inc

Dec 13 • 04:00PM ET

3.19

Dollar change +0.04
Percentage change 1.27	%

Healthcare • Medical Devices • USA • NASD

Peers: ISRG BSX MDT JNJ SYK ABT EW ZBH HOLX ALGN

| Held by: IWC VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-14.38	Insider Own	32.59%	Shs Outstand	1.15M	Perf Week	-19.24%
Market Cap	5.71M	Forward P/E	-	EPS next Y	-10.80	Insider Trans	0.00%	Shs Float	0.78M	Perf Month	-68.91%
Income	-14.03M	PEG	-	EPS next Q	-2.40	Inst Own	27.19%	Short Float	4.69%	Perf Quarter	-79.84%
Sales	0.00M	P/S	-	EPS this Y	26.37%	Inst Trans	-	Short Ratio	0.07	Perf Half Y	-89.08%
Book/sh	2.63	P/B	1.21	EPS next Y	-45.95%	ROA	-	Short Interest	0.04M	Perf Year	-
Cash/sh	2.88	P/C	1.11	EPS next 5Y	-	ROE	-	52W Range	3.01 - 152.00	Perf YTD	-96.85%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-340.96%	52W High	-97.90%	Beta	-
Dividend TTM	-	Quick Ratio	4.26	Sales past 5Y	0.00%	Gross Margin	-	52W Low	5.98%	ATR (14)	1.13
Dividend Ex-Date	-	Current Ratio	4.26	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	29.11	Volatility	8.87% 12.61%
Employees	8	Debt/Eq	0.36	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	28.00
Option/Short	No / Yes	LT Debt/Eq	0.36	EPS Q/Q	-168.82%	Payout	-	Rel Volume	0.10	Prev Close	3.15
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	Nov 12 AMC	Avg Volume	530.44K	Price	3.19
SMA20	-50.77%	SMA50	-65.78%	SMA200	-88.92%	Trades		Volume	50,542	Change	1.27%

Dec-05-24 08:30AM	Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025 (GlobeNewswire) -6.72%
Nov-25-24 04:00PM	Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option (GlobeNewswire) -5.21%
Nov-22-24 09:15AM	Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering (GlobeNewswire) -53.55%
Nov-11-24 08:00AM	Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update (GlobeNewswire)
Oct-31-24 08:00AM	Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients' 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction (GlobeNewswire) +39.75%
08:30AM	Loading…
Oct-30-24 08:30AM	Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial (GlobeNewswire)
Oct-28-24 08:00AM	Positive Preliminary Results Demonstrate Autonomix's Proprietary RF Ablation Technology's Ability to Reduce Opioid Use in Ongoing Human Clinical Trial (GlobeNewswire) +60.57%
Oct-25-24 11:30AM	Autonomix Medical, Inc. to Participate in a Virtual Investor What This Means Segment on Wednesday, October 30th (GlobeNewswire) -22.12%
Oct-22-24 08:30AM	Autonomix Announces Reverse Stock Split (GlobeNewswire)
Oct-08-24 08:30AM	Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC (GlobeNewswire)
Oct-03-24 08:35AM	This Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic Cancer (News Direct)
Sep-26-24 07:30AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment (GlobeNewswire)
Sep-20-24 08:30AM	Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum (GlobeNewswire)
Sep-09-24 07:00AM	Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients (GlobeNewswire) +9.09%
Aug-27-24 08:30AM	Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
08:30AM	Loading…
Aug-21-24 08:30AM	Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress (GlobeNewswire)
Aug-13-24 08:00AM	Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones (GlobeNewswire)
Aug-02-24 08:30AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment (GlobeNewswire) -23.30%
Jul-24-24 08:00AM	Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology (GlobeNewswire)
Jul-22-24 09:05AM	Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series (GlobeNewswire) +9.22%
Jul-18-24 08:30AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor What This Means Segment Covering Technology License Agreement (GlobeNewswire) +10.66%
Jul-16-24 08:25AM	Why Is Autonomix Medical (AMIX) Stock Down 17% Today? (InvestorPlace) -23.19%
07:43AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
Jul-15-24 01:48PM	Why Is Autonomix Medical (AMIX) Stock Up 120% Today? (InvestorPlace) +123.30%
01:30PM	Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer (ACCESSWIRE)
08:00AM	Autonomix Enters into Definitive Agreement to License Intellectual Property for FDA-Cleared Ablation Technology from RF Innovations, Inc. (GlobeNewswire)
Jul-12-24 08:45AM	Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer (News Direct) +6.55%
Jul-11-24 09:00AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Launch of CEO Corner Platform (GlobeNewswire) +7.21%
Jul-03-24 09:00AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor What This Means Segment (GlobeNewswire) -31.76%
Jun-18-24 08:00AM	Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial (GlobeNewswire) -17.04%
04:05PM	Loading…
Jun-17-24 04:05PM	Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer (GlobeNewswire) -7.53%
Jun-10-24 08:00AM	Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024 (GlobeNewswire) -9.49%
Jun-06-24 09:00AM	This One Company Is Working On A Breakthrough Approach To Revolutionize Pain Management (News Direct) -9.09%
Jun-03-24 02:52PM	AMIX Stock Earnings: Autonomix Medical Reported Results for Q4 2024 (InvestorPlace) -10.53%
08:15AM	Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial (GlobeNewswire)
May-31-24 08:05AM	Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire) +7.55%
May-23-24 09:15AM	Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer (GlobeNewswire) -5.91%
May-14-24 04:15PM	Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series (GlobeNewswire)
Apr-25-24 08:30AM	Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip (GlobeNewswire) +6.84%
Apr-24-24 09:00AM	Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar (GlobeNewswire)
Apr-16-24 09:00AM	Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain (GlobeNewswire) -5.42%
Apr-15-24 12:03PM	Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology (News Direct)
Apr-11-24 08:55AM	Autonomix Medical (NASDAQ: AMIX) Is Cracking the Code Of The Peripheral Nervous System With Its Breakthrough Technology To Treat Diseases (News Direct)
Apr-09-24 08:30AM	Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation (GlobeNewswire)
Apr-08-24 08:30AM	Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker (GlobeNewswire)
Mar-27-24 09:00AM	Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference (GlobeNewswire)
Mar-20-24 08:05AM	Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024 (GlobeNewswire)
Mar-19-24 08:45AM	Autonomix Appoints Jennifer Cook as Chief Business Officer (GlobeNewswire)
Mar-14-24 08:15AM	Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market (GlobeNewswire) +16.33%
Mar-06-24 08:00AM	Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market (GlobeNewswire) -7.08%
Feb-29-24 08:30AM	Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial (GlobeNewswire) -7.83%
Feb-23-24 08:50AM	Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity (GlobeNewswire) +10.20%
Feb-22-24 08:00AM	Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study (GlobeNewswire)
Feb-16-24 08:00AM	Autonomix Begins Human POC Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market (GlobeNewswire)
Feb-14-24 08:05AM	Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones (GlobeNewswire) -10.15%
Feb-09-24 08:45AM	Autonomix Medical, Inc. (NASDAQ:AMIX) to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference (ACCESSWIRE)
Feb-06-24 08:50AM	Autonomix Medical, Inc. Receives Ethics Committee Authorization for Proof-of-Concept Human Clinical Study Evaluating Proprietary Ablation Technology for Treatment of Pancreatic Cancer Pain (GlobeNewswire)
Feb-01-24 08:35AM	Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street Event (GlobeNewswire) +10.79%
Jan-31-24 08:45AM	Autonomix Medical, Inc. to Ring the Nasdaq Stock Market Closing Bell on Thursday, February 1, 2024 (GlobeNewswire)
Jan-30-24 12:00PM	Autonomix Medical, Inc. Completes $8,000,000 Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use Over 100 patents in portfolio (GlobeNewswire)
09:05AM	Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use (GlobeNewswire)
Jan-29-24 08:05AM	Autonomix Medical, Inc. (NASDAQ: AMIX) Commences Trading on NASDAQ (GlobeNewswire)

Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies. The company was founded by Robert Schwartz, Landy Toth, David A. Robins, and Robert A. Van Tassel on June 10, 2014 and is headquartered in Doylestown, PA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AMIX

Autonomix Medical Inc

Upgrade your FINVIZ experience